20 May 2013
Keywords: USA, FDA, Consumer understanding, Transparency, Regulation
Article | 13 January 2010
The US Food and Drug Administration yesterday unveiled the first phase of its Transparency Initiative, which is designed to explain ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 January 2010
© 2013 thepharmaletter.com